Drug resistance, which is often of a multiple type, can be defined as the ability of cancer cells to obtain resistance to both conventional and novel chemotherapy agents. It remains a major problem to solve in cancer therapy. The mechanisms of resistance are multifactorial, and in our cellular models of acute myeloid leukemia, hepatocellular carcinoma, and triple-negative breast cancer, it involves the NF-κB pathway. In our opinion, multitarget molecules can be considered as privileged compounds capable of attacking and reversing the resistant phenotype. In the phenomena of both innate and acquired drug resistance that we have been studying since 1998 to today and up to 2016 under the guidance of Professor Natale D’Alessandro, more strictly pharmacological factors are certainly involved. These factors include P-glycoprotein and biological factors such as inhibitory proteins; apoptosis; the Raf-1 kinase inhibitor protein, an important tumor suppressor and metastasis inhibitor, which enhances drug-induced apoptosis of cancer cells; and Yin Yang, a transcription factor involved in drug resistance.

Paola Poma, M.L. (2021). Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It. CRITICAL REVIEWS IN ONCOGENESIS, 26(2), 27-37 [10.1615/CritRevOncog.2020036247].

Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It

Paola Poma
Primo
;
Manuela Labbozzetta
Secondo
;
Monica Notarbartolo
Ultimo
2021-02-17

Abstract

Drug resistance, which is often of a multiple type, can be defined as the ability of cancer cells to obtain resistance to both conventional and novel chemotherapy agents. It remains a major problem to solve in cancer therapy. The mechanisms of resistance are multifactorial, and in our cellular models of acute myeloid leukemia, hepatocellular carcinoma, and triple-negative breast cancer, it involves the NF-κB pathway. In our opinion, multitarget molecules can be considered as privileged compounds capable of attacking and reversing the resistant phenotype. In the phenomena of both innate and acquired drug resistance that we have been studying since 1998 to today and up to 2016 under the guidance of Professor Natale D’Alessandro, more strictly pharmacological factors are certainly involved. These factors include P-glycoprotein and biological factors such as inhibitory proteins; apoptosis; the Raf-1 kinase inhibitor protein, an important tumor suppressor and metastasis inhibitor, which enhances drug-induced apoptosis of cancer cells; and Yin Yang, a transcription factor involved in drug resistance.
Settore BIO/14 - Farmacologia
https://www.dl.begellhouse.com/journals/439f422d0783386a,7c5b8f694e2aed89,4cce5ac50b482ec6.html#
Paola Poma, M.L. (2021). Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It. CRITICAL REVIEWS IN ONCOGENESIS, 26(2), 27-37 [10.1615/CritRevOncog.2020036247].
File in questo prodotto:
File Dimensione Formato  
CRO-36247.pdf

Solo gestori archvio

Descrizione: Articolo principale
Tipologia: Versione Editoriale
Dimensione 433.02 kB
Formato Adobe PDF
433.02 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/519566
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact